The best offense? CCR5 inhibitors, with one now on the market, suggest it may be a good defense
Stem cells and gene therapy: Researchers take a second look at using stem cells to treat HIV
Solving the viral spike: Can structural biology find a chink in HIV's armor?
Reconstructing early HIV: The search for immunogens delves into the virus' past
Profile: A Receptive Leader: Panacos' Graham Allaway
In a bustling laboratory at the University of Pennsylvania's Wistar Institute, Hildegund Ertl, director of the Wistar's recently established Vaccine Center, stands at a centrifuge waiting for her tubes to stop spinning. At another end of the laboratory bits of mouse vaginal tract shake in jars of pink collagenase, while at a microscope a student counts fuzzy, spherical lymphocytes.
Ertl's ...